Patents by Inventor Yasunori Okada

Yasunori Okada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116364
    Abstract: A virtual image display apparatus includes a housing having a first housing part and a second housing part. The first housing part is located on a side facing in a first direction. The second housing part is located on a side facing in a second direction being opposite to the first direction. A composite wall is located at the housing on a side facing in a third direction being perpendicular to the first direction. The composite wall includes a first front wall portion and a second front wall portion. The first front wall portion is extended from the first housing part. The second front wall portion is extended from the second housing part. The first and second front wall portions have an interference avoidance structure that avoids interference when the first and second front wall portions approach each other by receiving a load.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 11, 2024
    Inventors: Yasunori NINOMIYA, Syunichi Okada, Yusuke Ohta, Kenta Futamura
  • Patent number: 11929771
    Abstract: A transmission system includes: an antenna; a control device including an RF circuit which transmits a first signal for controlling a radio wave to be outputted from the antenna and an external power supply which supplies direct current to the antenna; and a first transmission path which connects the antenna and the control device, and is used in transmission of the first signal and supplying of the direct current to the antenna.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: March 12, 2024
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Satoshi Kaga, Toshihiro Nagayama, Hiroaki Kobayashi, Yasunori Komukai, Shinichi Okada, Yasumichi Takai, Yoshinori Hiramatsu
  • Publication number: 20230332356
    Abstract: A laminated article includes a base layer and a coating layer disposed over at least one side of the base layer. The coating layer contains a poly(3-hydroxybutyrate) resin. In a crystalline melting curve obtained by differential scanning calorimetry of the coating layer, the coating layer has at least one peak top temperature (Tma) in the range of 100 to 150° C. and at least one peak top temperature (Tmb) in the range of 150 to 170° C., and the difference between the temperatures Tma and Tmb is 10° C. or more.
    Type: Application
    Filed: September 9, 2021
    Publication date: October 19, 2023
    Applicant: KANEKA CORPORATION
    Inventors: Asuka FUKUTOME, Yasunori OKADA, Tetsuo OKURA, Kensuke MURASHIMA
  • Publication number: 20230287626
    Abstract: An object of the present invention is to provide a coated paper that includes a coating layer containing poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with few coating defects. As a solution, the present invention provides a coated paper including a coating layer containing poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and an adhesive, on at least one side of a paper substrate. A solid content weight ratio of the poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) to the adhesive in the coating layer is 99.9/0.1 to 60.0/40.0.
    Type: Application
    Filed: June 10, 2021
    Publication date: September 14, 2023
    Inventors: Hirosuke TSUNODA, Yoshio YOSHIDA, Koji KUTSUWA, Tetsuo OKURA, Yasunori OKADA, Asuka FUKUTOME
  • Patent number: 10640573
    Abstract: The present invention provides an antibody that specifically binds to human aggrecanase, and inhibits enzymatic activity of the human aggrecanase. In one embodiment, aggrecanase is ADAMTS4. In one embodiment, the antibody recognizes a particular epitope in human ADAMTS4, and inhibits not only aggrecanase activity of human ADAMTS4 but also aggrecanase activity of human ADAMTS5. In addition, the present invention also provides use of said antibody in the prophylaxis or treatment of the progression of arthritis.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 5, 2020
    Assignees: GeneFrontier Corporation, Keio University
    Inventors: Akira Miyakoshi, Mikiko Nakamura, Kanehisa Kojoh, Satsuki Mochizuki, Yasunori Okada
  • Patent number: 10556967
    Abstract: The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: February 11, 2020
    Assignees: GENEFRONTIER CORPORATION, KEIO UNIVERSITY
    Inventors: Akira Miyakoshi, Rena Matsumoto, Shizue Katoh, Yuki Hayami, Satsuki Mochizuki, Masayuki Shimoda, Yasunori Okada
  • Publication number: 20190233541
    Abstract: The present invention provides an antibody that specifically binds to human aggrecanase, and inhibits enzymatic activity of the human aggrecanase. In one embodiment, aggrecanase is ADAMTS4. In one embodiment, the antibody recognizes a particular epitope in human ADAMTS4, and inhibits not only aggrecanase activity of human ADAMTS4 but also aggrecanase activity of human ADAMTS5. In addition, the present invention also provides use of said antibody in the prophylaxis or treatment of the progression of arthritis.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 1, 2019
    Applicants: GeneFrontier Corporation, Keio University
    Inventors: Akira MIYAKOSHI, Mikiko NAKAMURA, Kanehisa KOJOH, Satsuki MOCHIZUKI, Yasunori OKADA
  • Patent number: 10329358
    Abstract: The present invention provides an antibody having an activity to specifically bind to human membrane-anchored form ADAM28 at an epitope in a region of the 524th-659th amino acids in the amino acid sequence shown in SEQ ID NO: 2. In addition, the present invention provides a drug delivery vehicle for delivering a drug to a cell or tissue that expresses human membrane-anchored form ADAM28, which contains the antibody.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: June 25, 2019
    Assignees: GeneFrontier Corporation, KEIO UNIVERSITY
    Inventors: Akira Miyakoshi, Kanehisa Kojoh, Satsuki Mochizuki, Masayuki Shimoda, Yasunori Okada
  • Publication number: 20180155448
    Abstract: The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.
    Type: Application
    Filed: November 16, 2017
    Publication date: June 7, 2018
    Applicants: GENEFRONTIER CORPORATION, KEIO UNIVERSITY
    Inventors: Akira MIYAKOSHI, Rena MATSUMOTO, Shizue KATOH, Yuki HAYAMI, Satsuki MOCHIZUKI, Masayuki SHIMODA, Yasunori OKADA
  • Publication number: 20180044435
    Abstract: The present invention provides an antibody having an activity to specifically bind to human membrane-anchored form ADAM28 at an epitope in a region of the 524th-659th amino acids in the amino acid sequence shown in SEQ ID NO: 2. In addition, the present invention provides a drug delivery vehicle for delivering a drug to a cell or tissue that expresses human membrane-anchored form ADAM28, which contains the antibody.
    Type: Application
    Filed: March 4, 2016
    Publication date: February 15, 2018
    Applicants: GeneFrontier Corporation, KEIO UNIVERSITY
    Inventors: Akira MIYAKOSHI, Kanehisa KOJOH, Satsuki MOCHIZUKI, Masayuki SHIMODA, Yasunori OKADA
  • Patent number: 9845364
    Abstract: The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: December 19, 2017
    Assignees: GeneFrontier Corporation, Keio University
    Inventors: Akira Miyakoshi, Rena Matsumoto, Shizue Katoh, Yuki Hayami, Satsuki Mochizuki, Masayuki Shimoda, Yasunori Okada
  • Patent number: 9662763
    Abstract: Provided is a polishing composition containing at least aluminum oxide abrasive grains and water, and having a pH of 8.5 or higher. The aluminum oxide abrasive grains have a specific surface area of 20 m2/g or less. It is preferable for the aluminum oxide abrasive grains to have an average secondary particle size of 0.1 ?m or more and 20 ?m or less. The polishing composition is used for polishing hard and brittle materials having a Vickers hardness of 1,500 Hv or higher, such as sapphire, silicon carbide, and gallium nitride.
    Type: Grant
    Filed: February 20, 2012
    Date of Patent: May 30, 2017
    Assignee: FUJIMI INCORPORATED
    Inventors: Hiroshi Asano, Kazusei Tamai, Yasunori Okada
  • Publication number: 20160304622
    Abstract: The present invention provides an antibody that specifically binds to human aggrecanase, and inhibits enzymatic activity of the human aggrecanase. In one embodiment, aggrecanase is ADAMTS4. In one embodiment, the antibody recognizes a particular epitope in human ADAMTS4, and inhibits not only aggrecanase activity of human ADAMTS4 but also aggrecanase activity of human ADAMTS5. In addition, the present invention also provides use of said antibody in the prophylaxis or treatment of the progression of arthritis.
    Type: Application
    Filed: October 14, 2014
    Publication date: October 20, 2016
    Applicants: GeneFrontier Corporation, Keio University
    Inventors: Akira MIYAKOSHI, Mikiko NAKAMURA, Kanehisa KOJOH, Satsuki MOCHIZUKI, Yasunori OKADA
  • Patent number: 9328271
    Abstract: An adhesive resin composition, including: a base resin which comprises (A) 30-90 parts by weight of a modified ethylene-olefin copolymer, and (B) 70-10 parts by weight of a styrene thermoplastic elastomer, provided that (A)+(B) equals 100 parts by weight; and (C) a tackifier in an amount of 30-60 parts by weight per 100 parts by weight of the base resin, the modified ethylene-olefin copolymer being one which has been graft-modified with (a) an unsaturated carboxylic acid or a derivative thereof and (b) an aromatic vinyl monomer, comprises 0.1%-5% by weight of (a) the unsaturated carboxylic acid or the derivative thereof, and has a melting point peak in a range of 100-150° C. with an enthalpy of crystal fusion of 0.5-10 J/g as determined by DSC.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: May 3, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Yasunori Okada, Takashi Matsumoto, Takao Michinobu
  • Publication number: 20150274840
    Abstract: The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.
    Type: Application
    Filed: October 1, 2013
    Publication date: October 1, 2015
    Inventors: Akira Miyakoshi, Rena Matsumoto, Shizue Katoh, Yuki Hayami, Satsuki Mochizuki, Masayuki Shimoda, Yasunori Okada
  • Publication number: 20130324015
    Abstract: Provided is a polishing composition containing at least aluminum oxide abrasive grains and water, and having a pH of 8.5 or higher. The aluminum oxide abrasive grains have a specific surface area of 20 m2/g or less. It is preferable for the aluminum oxide abrasive grains to have an average secondary particle size of 0.1 ?m or more and 20 ?m or less. The polishing composition is used for polishing hard and brittle materials having a Vickers hardness of 1,500 Hv or higher, such as sapphire, silicon carbide, and gallium nitride.
    Type: Application
    Filed: February 20, 2012
    Publication date: December 5, 2013
    Applicant: Fujimi Incorporated
    Inventors: Hiroshi Asano, Kazusei Tamai, Yasunori Okada
  • Patent number: 8445652
    Abstract: An object of the present invention is to provide a 3,6-O-bridged pyranose-inverted compound useful for being easy to produce ?-O-pyranosides selectively. The 3,6-O-bridged pyranose-inverted compound according to the present invention is represented by General Formula (1): wherein RA and RB each represent hydrogen or are bonded to each other to form a benzene ring; one of RC and RD represents hydrogen and the other represents —OR2; R1 represents hydroxy or halogen; and R2 and R3 each represent a hydroxy-protecting group.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: May 21, 2013
    Assignee: Kwansei Gakuin Educational Foundation
    Inventors: Hidetoshi Yamada, Noriaki Asakura, Yasunori Okada
  • Publication number: 20130108827
    Abstract: An adhesive resin composition, including: a base resin which comprises (A) 30-90 parts by weight of a modified ethylene-olefin copolymer, and (B) 70-10 parts by weight of a styrene thermoplastic elastomer, provided that (A)+(B) equals 100 parts by weight; and (C) a tackifier in an amount of 30-60 parts by weight per 100 parts by weight of the base resin, the modified ethylene-olefin copolymer being one which has been graft-modified with (a) an unsaturated carboxylic acid or a derivative thereof and (b) an aromatic vinyl monomer, comprises 0.1%-5% by weight of (a) the unsaturated carboxylic acid or the derivative thereof, and has a melting point peak in a range of 100-150° C. with an enthalpy of crystal fusion of 0.5-10 J/g as determined by DSC.
    Type: Application
    Filed: April 8, 2011
    Publication date: May 2, 2013
    Applicant: KANEKA CORPORATION
    Inventors: Yasunori Okada, Takashi Matsumoto, Takao Michinobu
  • Publication number: 20100324275
    Abstract: An object of the present invention is to provide a 3,6-O-bridged pyranose-inverted compound useful for being easy to produce ?-O-pyranosides selectively. The 3,6-O-bridged pyranose-inverted compound according to the present invention is represented by General Formula (1): wherein RA and RB each represent hydrogen or are bonded to each other to form a benzene ring; one of RC and RD represents hydrogen and the other represents —OR2; R1 represents hydroxy or halogen; and R2 and R3 each represent a hydroxy-protecting group.
    Type: Application
    Filed: February 13, 2009
    Publication date: December 23, 2010
    Inventors: Hidetoshi Yamada, Noriaki Asakura, Yasunori Okada
  • Publication number: 20060292147
    Abstract: A blood matrix metalloprotease-3 (MMP-3) level-lowering agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
    Type: Application
    Filed: September 1, 2006
    Publication date: December 28, 2006
    Inventors: Kazuyuki Yoshizaki, Norihiro Nishimoto, Yasunori Okada, Ken-ichi Obata